Franklin International Core Equity Fund (TSX:FCRI)
25.11
-0.12 (-0.48%)
At close: Jun 26, 2026
20.84% (1Y)
| Assets | 22.61M |
| Expense Ratio | n/a |
| PE Ratio | 16.21 |
| Dividend (ttm) | 0.64 |
| Dividend Yield | 2.54% |
| Ex-Dividend Date | Dec 30, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 38.01% |
| 1-Year Return | n/a |
| Volume | 700 |
| Open | 25.11 |
| Previous Close | 25.23 |
| Day's Range | 25.11 - 25.11 |
| 52-Week Low | 20.60 |
| 52-Week High | 25.26 |
| Beta | n/a |
| Holdings | 215 |
| Inception Date | Jun 25, 2025 |
About FCRI
Franklin International Core Equity Fund is an exchange traded fund launched and managed by Franklin Templeton Investments Corp. It is co-managed by Franklin Advisers, Inc. It invests in public equity markets of global developed ex-US/Canada. It invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against the MSCI EAFE Index. Franklin International Core Equity Fund was formed on May 6, 2025 and is domiciled in Canada.
Asset Class Equity
Category Total Market
Stock Exchange Toronto Stock Exchange
Ticker Symbol FCRI
Provider Franklin
Top 10 Holdings
19.66% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.75% |
| HSBC Holdings plc | HSBA | 2.38% |
| Novartis AG | NOVN | 2.08% |
| Mitsubishi UFJ Financial Group, Inc. | 8306 | 1.94% |
| Shell plc | SHEL | 1.88% |
| Roche Holding AG | ROP | 1.87% |
| Cad | n/a | 1.86% |
| ABB Ltd | ABBN | 1.74% |
| Tokyo Electron Limited | 8035 | 1.62% |
| AstraZeneca PLC | AZN | 1.55% |